1. Trang chủ
  2. » Nông - Lâm - Ngư

FOOD SAFETY, heavy metals, pages 344 351, g l klein

8 276 0

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 8
Dung lượng 241,71 KB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

Manifestations of Lead Toxicity Perhaps due to their increased absorption of lead from the diet, children appear to be more susceptible to the toxic effects of lead.. Although peripheral

Trang 1

significance of such findings has not been

estab-lished, but the studies clearly indicate that

perchlo-rate can enter lettuce, presumably from growing

conditions in which perchlorate has contaminated

water or soil

Milk has also been shown to be subject to

per-chlorate contamination A small survey of seven

milk samples purchased in Lubbock, Texas,

indi-cated that perchlorate was present in all of the

sam-ples at levels ranging from 1.12 to 6.30 mg/l To put

such findings in perspective, the State of California

has adopted an action level of 4 mg/l for perchlorate

in drinking water, whereas the EPA has yet to

estab-lish a specific drinking water limit

Toxicological Considerations

Perchlorate is thought to exert its toxic effects at

high doses by interfering with iodide uptake into

the thyroid gland This inhibition of iodide uptake

can lead to reductions in the secretion of thyroid

hormones that are responsible for the control of

growth, development, and metabolism Disruption

of the pituitary–hypothalamic–thyroid axis by

per-chlorate may lead to serious effects, such as

carci-nogenicity, neurodevelopmental and developmental

changes, reproductive toxicity, and

immunotoxi-city Specific concerns relate to the exposures of

infants, children, and pregnant women because

the thyroid plays a major role in fetal and child

development

The ability of perchlorate to interfere with iodide

uptake is due to its structural similarity with iodide

In recognition of this property, perchlorate has been

used as a drug in the treatment of hyperthyroidism

and for the diagnosis of thyroid or iodine

metabo-lism disorders

Ammonium perchlorate was found to be

nonge-notoxic in a number of tests, which is consistent

with the fact that perchlorate is relatively inert

under physiological conditions and is not

metabo-lized to active metabolites in humans or in test

animals

Workers exposed to airborne levels of perchlorate

absorbed between 0.004 and 167 mg perchlorate per

day These workers showed no evidence of thyroid

abnormality, and a No Observed Adverse Effect

Level was established at 34 mg absorbed

perchlo-rate/day Perchlorate does not accumulate in the

human body, and 85–90% of perchlorate given to

humans is excreted in the urine within 24 h

See also: Cancer: Epidemiology and Associations

Between Diet and Cancer Fish Food Intolerance

Food Safety: Mycotoxins; Pesticides; Bacterial

Contamination; Heavy Metals

Further Reading Becher G (1998) Dietary exposure and human body burden of dioxins and dioxin-like PCBs in Norway Organohalogen Compounds 38: 79–82.

Buckland SJ (1998) Concentrations of PCDDs, PCDFs and PCBs

in New Zealand retain foods and assessment of dietary expo-sure Organohalogen Compounds 38: 71–74.

Environmental Protection Agency (2001) Dioxin: Scientific Highlights from Draft Reassessment Washington, DC: US Environmental Protection Agency, Office of Research and Development.

Food and Drug Administration (2002) Exploratory Data on Acry-lamide in Foods Washington, DC: US Food and Drug Admin-istration, Center for Food Safety and Applied Nutrition Friedman M (2003) Chemistry, biochemistry, and safety of acry-lamide A review Journal of Agricultural and Food Chemistry 51: 4504–4526.

Jimenez B (1996) Estimated intake of PCDDs, PCDFs and co-planar PCBs in individuals from Madrid (Spain) eating an average diet Chemosphere 33: 1465–1474.

Kirk AB, Smith EE, Tian K, Anderson TA, and Dasgupta PK (2003) Perchlorate in milk Environmental Science and Tech-nology 37: 4979–4981.

Sharp R and Walker B (2003) Rocket Science: Perchlorate and the Toxic Legacy of the Cold War Washington, DC: Environmen-tal Working Group.

Tareke E, Rydberg P, Karlsson P, Eriksson S, and Tornqvist M (2002) Analysis of acrylamide, a carcinogen formed in heated foodstuffs Journal of Agricultural and Food Chemistry 50: 4998–5006.

Urbansky ET (2002) Perchlorate as an environmental contaminant Environmental Science and Pollution Research 9: 187–192 Zanotto E (1999) PCDD/Fs in Venetian foods and a quantitative assessment of dietary intake Organohalogen Compounds 44: 13–17.

Heavy Metals

G L Klein, University of Texas Medical Branch at Galveston, Galveston TX, USA

ª 2005 Elsevier Ltd All rights reserved.

Food that we are culturally habituated to consume is usually thought to be safe However, some foods are naturally contaminated with substances, the effects

of which are unknown Crops are sprayed with pesticides while they are being cultivated; some ani-mals are injected with hormones while being raised Meanwhile, other foods are mechanically processed

in ways that could risk contamination This article discusses food contamination with heavy metals, the heavy metals involved, their toxicities, and their sources in the environment A brief consideration

of medical management is also included Five metals are considered in this category: lead, mercury, cad-mium, nickel, and bismuth

Trang 2

How Does Lead Contaminate Food?

Although lead is primarily known as an

environmen-tal contaminant that is ingested in paint chips by

young children in urban slums or from

contami-nated soil or inhaled in the form of house dust or

automobile exhaust, it may also enter the food and

water supply Ways in which this can occur include

fuel exhaust emissions from automobiles that may

contaminate crops and be retained by them,

espe-cially green leafy vegetables Animals used for food

may graze on contaminated crops and thus may also

be a potential source of lead Moreover, lead from

soldered water pipes may contaminate tap water

used for drink or for food production

Permissible Intakes

In the United States, the maximum quantity of lead in

the water supply that is permitted by the

Environ-mental Protection Agency is 15 mg (0.07 mmol l1)

The Food and Drug Administration (FDA) Advisory

Panel recommends that no more than 100 mg

(50 mmol) of lead per day should be ingested from

food products

Dietary Lead: Absorption and Consequences

People with certain macronutrient and

micronutri-ent deficiencies are prone to experience increased

absorption of lead in the diet Thus, depletion of

iron, calcium, and zinc may promote lead

absorp-tion through the gastrointestinal tract Whereas

adults may normally absorb approximately 15% of

their lead intake, pregnant women and children may

absorb up to 3.5 times that amount, and the

expla-nation for this difference is not clear

The effects of the entry of lead into the circulation

depend on its concentration Thus, the inhibition of

an enzyme active in hemoglobin synthesis, -amino

levulinic acid dehydratase (ALAD), occurs at blood

lead concentrations of 5–10 mg dl1(0.25–0.5 mmol l1)

Another enzyme active in heme biosynthesis,

erythrocyte ferrochelatase, is inhibited at a blood

lead level of 15 mg dl1 (0.75 mmol l1) Reduction

of the renal enzyme 25-hydroxyvitamin D-1-

hydroxylase, which converts circulating

25-hydroxy-vitamin D to its biologically active steroid hormone,

1,25-dihydroxyvitamin D (1,25(OH)2D) or

calci-triol, is observed at a blood lead concentration of

25 mg dl1 (1.25 mmol l1) Behavioral changes and

learning problems may begin to occur at blood

levels previously thought to be normal, 10–15 mg dl1

(0.5–0.75 mmol l1)

Manifestations of Lead Toxicity Perhaps due to their increased absorption of lead from the diet, children appear to be more susceptible

to the toxic effects of lead These involve the ner-vous system, including cognitive dysfunction; the liver; the composition of circulating blood; kidney function; the vitamin D endocrine system and bone (Table 1); and gene function, possibly with resultant teratogenic effects Chronic exposure results in high blood pressure, stroke, and end-stage kidney disease

in adults

Neurologic Full-blown lead encephalopathy, includ-ing delirium, truncal ataxia, hyperirritability, altered vision, lethargy, vomiting, and coma, is not com-mon Although peripheral nerve damage and paraly-sis may still be reported in adults, the most common toxicity observed is learning disability and an asso-ciated high-frequency hearing loss occurring in chil-dren with blood lead levels previously assumed to be safe At low blood levels of lead (less than

10 mg dl1), children may lose IQ points, possibly due to the interference of lead in normal calcium signaling in neurons and possibly by blocking the recently reported learning-induced activation of calcium/phospholipid-dependent protein kinase C in the hippocampus

The physicochemical basis of these changes derives largely from small animal data Rats exposed to lead from birth develop mitochondrial dysfunction, neu-ronal swelling, and necrosis in both the cerebrum and the cerebellum Exposure on day 10 of life elicited only the cerebellar pathology, and lead exposure after

31

2weeks of life failed to produce any of these changes In combination with manganese, lead has also produced peroxidative damage to rat brains and has been shown to inhibit nitric oxide synthase

in the brains of mice Additionally, an increase in blood arachidonic acid and in the ratio of arachidonic

to linoleic acid following lead exposure in several species, including humans, may provide evidence in support of a peroxidative mechanism of damage to neural tissue following lead exposure

Lead has also produced necrosis of retinal photo-receptor cells and swelling of the endothelial lining

of retinal blood vessels in rats Lead may also damage the auditory nerves in rats, and it may be partially responsible for the high-frequency hearing loss observed in humans Finally, organic lead compounds may also disturb brain microtubular assembly

Liver Although there are no outwardly recognizable manifestations of lead toxicity to the liver, studies in

Trang 3

rats indicate that amino acid binding to hepatocyte

nuclei may be altered by lead Thus, liver function

may be subtly or subclinically affected and further

studies are needed to elucidate this possibility

Blood composition The major consequences of lead

toxicity to the blood are microcytic anemia and

decreased erythrocyte survival The anemia is largely

due to the inhibition of ALAD and erythrocyte

ferro-chelatase, which are critical to heme biosynthesis

Although the pathogenesis of the decreased red blood

cell survival is not clear in humans, animal data

indi-cate that the pentose phosphate shunt and

glucose-6-phosphate dehydrogenase (G6PD) are inhibited by

lead, suggesting that increased hemolysis may also

contribute to the reduction in erythrocyte survival

Kidney function Studies from the US National

Institute of Occupational Safety and Health have

reported that lead exposure reduced glutathione

S-transferase expression in the kidneys of rabbits,

indicating increased susceptibility to peroxidative

damage Renal proximal tubular dysfunction is

described with lead intoxication and can result in

glycosuria, aminoaciduria, and hyperphosphaturia

as well as a reduced natriuretic response to volume

expansion This latter effect of lead exposure may possibly offer an explanation of how lead accumula-tion may contribute to hypertension

Vitamin D endocrine system and bone As previously mentioned, lead can contribute to the reduced con-version of 25-hydroxyvitamin D to 1,25(OH)2D The extent to which this action may contribute to vitamin D deficiency is not known, but there is at least the potential for lower circulating levels of 1,25(OH)2D to play a role in reduced intestinal calcium absorption This in turn may result in further lead absorption Additionally, lead accumu-lating in bone has been reported to cause osteo-clasts to develop pyknotic nuclei and manifest inclusion bodies, possibly lead, in the nucleus and cytoplasm Although it has yet to be proven, these findings suggest a reduction in the resorptive func-tion of osteoclasts This may be a protective mechanism by the body to prevent the liberation

of lead stored in bone, but at the same time lead may prevent the uptake by bone of additional calcium

Genetic/teratogenic effects Lead has been reported

to alter gene transcription by the reduction of DNA

Table 1 Heavy metal toxicities by tissues

Tissue Heavy metal Dietary source(s) Toxicity

Neurologic Lead Green, leafy vegetables,

canned food with lead solder, water

Learning disability, ataxia, encephalopathy, irritability

Mercury Seafood, agricultural crop

contamination

Psychomotor retardation, paralysis, microcephaly, convulsions, choreoathetotic movements Bismuth Medications Paraesthesias, tremors, ataxia, reduced short-term memory Bone Lead See above Reduced conversion of vitamin D to active form,

?reduced osteoclast function Mercury See above ?Reduced bone formation and bone density Cadmium Seafood, plant roots in

contaminated soil

?High bone turnover, secondary hyperparathyroidism Bone marrow Lead See above Decreased hemoglobin synthesis, decreased erythrocyte

survival Mercury See above Increased hemolysis, alteration of T helper and

T suppressor lymphocytes Cadmium See above ?Reduced erythrocyte count Nickel Vegetables, especially

legumes, spinach and nuts

Decreased helper T cells and increased suppressor

T cells Gastrointestinal Lead See above Decreased binding of L -tryptophan to hepatocellular nuclei

Mercury See above Anorexia, fetal hepatic cell damage Cadmium See above Abdominal pain, vomiting, diarrhea Renal Lead See above Proximal tubular dysfunction: glycosuria, aminoaciduria,

hyperphosphaturia, decreased renal conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D, the biologically active form

Mercury See above Renal tubular dysfunction, proteinuria, autoimmune

damage Cadmium See above Proteinuria, glycosuria

Trang 4

binding to zinc finger proteins This interruption of

transcription has the potential to produce congenital

anomalies in animals or humans Studies have

reported that lead crossing the placenta has

pro-duced urogenital, vertebral, and rectal

malforma-tions in the fetuses of rats, hamsters, and chick

Management

Chelation therapy with dimercaprol succinic acid is

recommended for anyone with a blood lead level

higher than 25 mg l1 (1.2 mmol l1), as shown in

Table 2

Mercury

How Does Mercury Contaminate Food?

The primary portal of mercury contamination of

food is via its industrial release into water, either

fresh or salt water, and its conversion to methyl

mercury by methanogenic bacteria As the marine

life takes up the methyl mercury, it works its way

into the food chain and is ultimately consumed by

humans This is the scenario that occurred

follow-ing the release of inorganic mercury from an

acet-aldehyde plant into Minimata Bay in Japan in

1956 and 1965 and is responsible for the so-called

‘Minimata disease.’ Furthermore, acid rain has

increased the amount of mercury available to be

taken up by the tissues of edible sea life and can

enhance the toxicity of certain fish An

unfortu-nate consequence of seafood contamination with

methyl mercury is the contamination of fish meal

used to feed poultry, resulting in mercury

accumu-lation in the poultry as well as in the eggs

Addi-tionally, mercury-containing pesticides can

contaminate agricultural products In Iraq in

1971 and 1972, wheat used in the baking of

bread was contaminated with a fungicide that

con-tained mercury

Permissible Intakes Limits of mercury intake set by the UN Food and Agriculture Organization (FAO) and the World Health Organization (WHO) are 0.3 mg per person per week, of which no more than 0.2 mg should be methyl mercury Furthermore, FAO and WHO have set limits of mercury contamination of foods as not

to exceed 50 parts per billion wet weight (50 mg l1) Hair mercury content is used as a marker of methyl mercury burden

Dietary Mercury: Absorption and Consequences Although the precise mechanism of mercury absorp-tion and transport has not been clarified, one possi-bility is its use of molecular mimicry Studies of methyl mercury show that it binds to reduced sulf-hydryl groups, including those in the amino acid cysteine and glutathione Methyl mercury-1-cysteine

is similar in conformation to the amino acid methio-nine and may be taken up by the methiomethio-nine trans-port system in the intestine Also, inasmuch as it has been shown that deep-frying of fish, with or without breading, will increase the mercury content, it has been postulated that mercury may be absorbed with the oil from the frying process

A Swedish study reported a direct correlation between the amount of seafood consumed by preg-nant mothers and the concentration of methyl mer-cury in their umbilical cord blood Although fetal tissue mercury concentration is generally lower than the maternal concentration, the exception to this is liver According to a Japanese study, mercury is stored in the fetal liver, bound to metallothionein With development, the amount of metallothionein decreases and the mercury in liver is redistributed primarily to brain and kidney In studies of offspring

of animals exposed to mercury vapors, behavioral changes have been detected

With regard to toxicity, mercury affects the skin, kidneys, nervous system, and marrow, with Table 2 Recommended management of toxic symptoms caused by heavy metal contaminants in food

Lead Dimercaptosuccinic acid Blood lead levels greater than 25 mg (1.2 mmol) l1; treatment of children with

blood levels exceeding 10 mg (0.5 mmol) l1advocated due to learning problems Mercury Dimercaptosuccinic acid Dimercaprol and D -penicillamine have also been used, but dimercaprol

complicated by increased amount of mercury in brain Cadmium Diethyldithiocarbamate Also used: dimercaprol, D -penicillamine, and dicalcium disodium EDTA

Nickel Insufficient studies for

recommended agent

Parenteral administration of diethyldithiocarbamide for acute toxicity may

be helpful but unproven Bismuth Insufficient studies for

recommended agent

Dimercaprol has been used anecdotally and reversed the symptoms of myoclonic encephalopathy; many choose to stop bismuth-containing drugs with a gradual resolution of symptoms

Trang 5

consequent effects on the blood cells, immune

sys-tem, and bone formation

Manifestations of Mercury Toxicity

Skin Mercury produces a symptom complex called

acrodynia Its main features are redness of the lips

and pharynx, a strawberry tongue, tooth loss, skin

desquamation, and pink or red fingertips, palms,

and soles The eyes are also affected, and

photopho-bia and conjunctivitis are seen In addition, there is

enlargement of the cervical lymph nodes, loss of

appetite, joint pain, and, occasionally, vascular

thromboses, possibly by the induction of platelet

aggregation, which has been shown in in vitro

experiments There is also a neurological component

to this symptom complex: irritability, weakness of

the proximal muscles, hypotonia, depressed reflexes,

apathy, and withdrawal

Kidneys Mercury has been hypothesized to

stimu-late T lymphocytes to produce a glomerular

anti-basement membrane antibody, which produces

suf-ficient damage to lead to the proteinuria observed

with mercury toxicity (Table 1) The basis for this

theory derives from studies in rats in which mercuric

chloride injection produced these antibodies, both as

IgG and IgM There was also an observed increase

in CD8þ (suppressor) T cells in the glomeruli In

addition, the rats developed proximal tubular

necro-sis However, it is not clear that this theory is

cor-rect because methyl mercury can induce apoptosis,

or programmed cell death, of the T lymphocytes,

possibly by damaging mitochondria and inducing

oxidative stress

Nervous system In the large epidemics of methyl

mercury ingestion reported in both Japan and Iraq,

infants were reported to have psychomotor

retarda-tion, flaccid paralysis, microcephaly, ataxia,

chor-eoathetotic motions of the hands, tonic seizures,

and narrowing of the visual fields (Table 1) Studies

of neonatal rats injected with methyl mercuric

chlor-ide reported postural and movement changes during

the fourth week of life These were associated with

degeneration of cortical interneurons, which

pro-duce -aminobutyric acid (GABA) as a

neurotrans-mitter In the caudate nucleus and putamen, these

GABAergic and somatostatin immunoreactive

inter-neurons manifested the abnormalities Pregnant rats

given methyl mercury by intraperitoneal injection

demonstrated rapid (within 2 h) effects on their

fetuses, including mitochondrial degeneration of

cerebral capillary endothelial cells, which led to

hemorrhage In turn, the bleeding disrupted normal neuronal migration

In addition, methyl mercury may disrupt neuronal microtubular assembly and, perhaps by molecular mimicry (as described previously), may bind to the sulfhydryl groups of glutathione, causing peroxida-tive injury to the neurons Following intracerebral injection in the rat, methyl mercuric chloride distri-butes in the Purkinje and Golgi cells of the cerebel-lum as well as in three different layers of cerebral cortical cells—III, IV, and VI

Mercury exposure in humans can result in deficits

in attention and concentration, especially under pressure of time deadlines One report suggests that this may be due to mercury damage to the posterior cingulate cortex, where these functions are regulated

Finally, in vitro studies of rat cerebellar granular cells suggested that incubation with methyl mer-cury caused an increased, although delayed, phos-phorylation of certain proteins The 12- to 24-h time course from mercury exposure to phosphor-ylation was believed to be consistent with the alteration of gene expression by mercury Thus, the effects of mercury on the nervous system are multiple

Bone marrow: Immune cells, blood cells, and bone formation A toxic effect of mercury on bone mar-row would explain the abnormalities in red cell production, immune cell production, and bone for-mation (Table 1); all of the cells involved arise from stem cells found in the marrow and are presumably affected by mercury

With regard to the immune cells, mercury induces

an autoimmune response manifested by an increase

in CD4þ(helper) and CD8þ(suppressor) T lympho-cytes and in B lympholympho-cytes in peripheral lymphoid tissue This may explain in part the autoimmune nephropathy as well as the enlarged lymph nodes

of acrodynia, previously described Additionally, mercury may impair integrin signaling pathways in neutrophils, which may give rise to neutrophil dysfunction

Hemolysis of red blood cells resulting from mer-cury exposure may be at least in part due to perox-idative damage inasmuch as studies on workers chronically exposed to mercury vapors demonstrate

a reduction in erythrocyte enzyme activity of glu-tathione peroxidase and superoxide dismutase, as well as in G6PD

Finally, although the effects of mercury exposure

on bone have not been studied in humans, experi-ments in mice indicate that the administration of an anti-metallothionein antibody and mercury results in

Trang 6

decreased biochemical markers of bone formation

and decreased bone mineral density The mechanism

for this is unknown, but mercury interference

with differentiation of osteogenic precursor cells is

postulated

Genetic/teratogenic effects The uptake and

redis-tribution of mercury by fetal hepatic tissue have

been previously discussed Abnormalities described

with in utero exposure to mercury during the

epi-demics in Japan and Iraq have included low birth

weight, malformation of the brain (both cerebrum

and cerebellum), an abnormal migratory pattern of

neurons, mental retardation, and failure to achieve

developmental milestones This remains a problem

today for pregnant women who consume seafood

The FDA recommends that intake of large predator

fish, such as swordfish and shark, be limited since

they contain large amounts of mercury Even tuna is

considered to contain more mercury than most other

seafood

Management

Chelation with dimercaptosuccinic acid is

recom-mended (Table 2)

Cadmium

How Does Cadmium Contaminate Food?

Cadmium enters the food chain in much the same

way that lead and mercury do—by means of

indus-trial contamination Cadmium is often used as a

covering of other metals or in the manufacture of

batteries and semiconductors; it readily transforms

into a gas as the metal ores are smelted The

cad-mium then condenses to form cadcad-mium oxide,

which deposits in soil and water near the source

Cadmium accumulates in lower marine life, such

as plankton, mollusks, and shellfish, and continues

through the food chain as these organisms are

con-sumed However, contamination of the human food

supply is limited by this route since cadmium is

toxic to fish and fish embryos In contrast to

sea-food, vegetables are affected differently because

cad-mium is taken up by the leaves and roots of plants,

so those near industrial sources may be very high in

cadmium

Permissible Intakes

A 1991 study of adults consuming rice

contami-nated with cadmium in the Kakehashi River Basin

of Ishikara, Japan, correlated cadmium intake with

renal tubular dysfunction and established a

maximum allowable intake of 110 mg per day.

Canadian studies have estimated daily intake in study populations to be approximately half that, and the French have estimated cadmium exposure

in the diet as being only 3 or 4 mg per day The

Provisional Tolerable Weekly Intake (PTWI)

estab-lished by FAO/WHO is 7 mg kg1 body weight per week, a slightly more conservative estimate than the Japanese study but still in general agreement with it

Dietary Cadmium: Absorption and Consequences Fortunately, only 2–8% of dietary cadmium is absorbed and significant cadmium ingestion is accompanied by vomiting Therefore, the gastroin-testinal route is not as significant as inhalation of dust particles as a source of significant exposure Manifestations of Toxicity

Toxic manifestations of cadmium ingestion include renal dysfunction, osteoporosis and bone pain, abdominal pain, vomiting and diarrhea, anemia, and bone marrow involvement (Table 1)

Gastrointestinal toxicity The mechanisms for cad-mium’s effects on the gastrointestinal tract are not certain Whether these toxicities stem from an irri-tative effect of the metal or whether there is cel-lular damage has not been resolved in animal or

in vitro studies One possibility is that in vitro studies of neural tissue suggest that cadmium blocks adrenergic and cholinergic synapses There-fore, it is possible that cadmium interferes with autonomic nervous system influence on gastroin-testinal motility

Renal toxicity Renal tubular dysfunction is mani-fest in patients with itai itai disease as glycosuria and proteinuria, including excessive excretion of

- and -microglobulin Approximately 50–75% of cadmium accumulation in the body occurs in the liver and kidneys Urinary cadmium excretion of

200 mg (1.78 mmol) g1 of renal cortical tissue has been associated with tubular dysfunction In the kidney, cadmium is bound to metallothionein When the amount of intracellular cadmium accumu-lation exceeds metallothionein binding capacity, this

is the point at which renal toxicity is hypothesized

to occur

Bone marrow and bone In short-term accumula-tion of cadmium in the marrow, there is a prolifera-tion of cells in the myeloid/monocyte category However, with longer term burden, marrow hypo-plasia is reported, including decreased production of

Trang 7

erythropoietin Although a reduction in marrow

cells may indicate that the osteogenic precursors in

the marrow may also be reduced (Table 1), this is

not borne out by studies both in humans and in rats

In these cases, biochemical markers of bone

forma-tion (osteocalcin) and resorpforma-tion

(deoxypyridino-line) are both increased, indicating a high turnover

state In rats, circulating parathyroid hormone

levels are also elevated, suggesting that the high

turnover is due to secondary hyperparathyroidism

and subsequent inability of the bone matrix to

mature and bind calcium and phosphate Parenteral

administration of 1,25-dihydroxyvitamin D has

been reported to decrease circulating parathyroid

hormone in the rat and to reduce bone turnover

Moreover, other animal studies report that

cad-mium interferes with hydroxyapatite nucleation

and growth, thus making it difficult for bone

matrix to bind to calcium

Management

Chelation therapy is recommended using calcium,

disodium ethylene diaminetetraacetic acid,

dimerca-prol, D-penicillamine, or diethyldithiocarbamate

(Table 2)

Nickel and Bismuth

Dietary Contamination

Nickel and bismuth are not considered to be

com-mon dietary contaminants Nickel is mainly inhaled

as a dust by workers, whereas bismuth is mainly

ingested in bismuth-containing medications such

as Pepto-Bismol Vegetables contain more nickel

than other foods, and high levels of nickel can be

found in legumes, spinach, lettuce, and nuts Baking

powder and cocoa powder may also contain

excess nickel, possibly by leaching during the

man-ufacturing process Soft drinking water and

acid-containing beverages can dissolve nickel from pipes

and containers Daily nickel ingestion can be as high

as 1 mg (0.017 mmol) but averages between 200 and

300 mg (3.4 and 5.1 mmol).

Permissible Intakes

The maximum permissible intake of nickel is not

known Bismuth intake is related to whole blood

bismuth levels If these levels exceed 100 mg l1,

bismuth-containing medication should be discontinued

Toxicity

Nickel ingestion by women resulted in an increase in

interleukin-5 levels 4 h after ingestion and a decrease

in CD4þand an increase in CD8þlymphocytes 24 h

following the nickel intake Thus, alterations in the immune response may be associated with excessive nickel ingestion, consistent with reports of tumor production in animals and humans by inhalation of nickel-containing dust or powders The mechanism for nickel-associated toxicity is purported to be oxi-dative For bismuth, neurotoxicity, including irrit-ability, numbness and tingling of the extremities, insomnia, poor concentration, impairment of short-term memory, tremors, dementia masquerading as Alzheimer’s disease, and abnormal electroencepha-lograms, has been reported Discontinuation of the bismuth may result in restoration of normal neuro-logical function Production of these symptoms in animals was associated with a brain bismuth

con-centration of 8 mg g1brain tissue; a brain bismuth

concentration of 4 mg g1 brain tissue was not associated with these neurotoxic manifestations

However, hydrocephalus was reported At 1 mg

bismuth g1 brain tissue, no neurotoxic features were observed in animals Nephropathy, osteoar-thropathy, and thrombocytopenia have also been reported with bismuth toxicity

Management Insufficient controlled clinical trials have been per-formed to make clear-cut recommendations for pharmacotherapy for toxicity from either nickel or bismuth Diethyl dithiocarbamide chelation therapy when promptly administered intravenously has been reported to be effective in acute nickel carbonyl poisoning In addition, there have been anecdotal case reports of the reversal of myoclonic encephalo-pathy caused by bismuth with use of dimercaprol However, no recommendations can be given at the present time

See also: Ascorbic Acid: Physiology, Dietary Sources and Requirements; Deficiency States Food Safety: Other Contaminants Vitamin D: Physiology, Dietary Sources and Requirements

Further Reading Bierer DW (1990) Bismuth subsalicylate: History, chemistry and safety Reviews of Infectious Disease 12(supplement 1): S3–S8.

Bjomberg KA, Vahter M, Peterson-Grawe K et al (2003) Methyl mercury and inorganic mercury in Swedish pregnant women and in cord blood: Influence of fish consumption Environ-mental Health Perspectives 111: 637–641.

Blumenthal NC, Cosma V, Skyler D et al (1995) The effect of cadmium on the formation and properties of hydroxyapatite

in vitro and its relation to cadmium toxicity in the skeletal system Calcified Tissue International 56: 316–322.

Trang 8

Burger J, Dixon C, Boring CS et al (2003) Effect of deep frying

fish on risk from mercury Journal of Toxicology and

Environmental Health 66: 817–828.

Jin GB, Inoue S, Urano T et al (2002) Induction of

anti-metallothionein antibody and mercury treatment decreases

bone mineral density in mice Toxicology and Applied

Phar-macology 115: 98–110.

Knowles S, Donaldson WE, and Andrews JK (1998) Changes in

fatty acid composition of lipids in birds, rodents, and

pre-school children exposed to lead Biological Trace Element

Research 61: 113–125.

Kollmeier H, Seeman JW, Rothe G et al (1990) Age, sex and region

adjusted concentrations of chromium and nickel in lung tissue.

British Journal of Industrial Medicine 47: 682–687.

Kurata Y, Katsuta O, Hiratsuka H et al (2001) Intravenous

1-,25 (OH) 2 vitamin D 3 (calcitriol) pulse therapy for bone

lesions in a murine model of chronic cadmium toxicosis

Inter-national Journal of Experimental Pathology 82: 43–53.

Murata K, Weche P, Renzoni A et al (1999) Delayed evoked

potential in children exposed to methylmercury from seafood.

Neurotoxicology and Teratology 21: 343–348.

Needleman HL, Schell A, Bellinger D et al (1990) The long-term effects of exposure to low doses of lead in childhood An 11-year follow-up report New England Journal of Medicine 322: 83–88 Report of the International Committee on Nickel Carcinogenesis

in Man (1990) Scandinavian Journal of Work and Environ-mental Health 49: 1–648.

Royce SC and Needleman HL (1990) Agency for Toxic Sub-stances and Disease Registry Case Studies in Environmental Medicine, pp 1–20 Atlanta: US Department of Health and Human Services, Public Health Service.

Simon JA and Hudes ES (1999) Relationship of ascorbic acid to blood lead levels Journal of the American Medical Associa-tion 281: 2289–2293.

Watanabe C, Yoshida K, Kasanume Y et al (1999) In utero methylmercury exposure differentially affects the activities of selenoenzymes in the fetal mouse brain Environmental Research 80: 208–214.

Worth RG, Esper RM, Warra NS et al (2001) Mercury inhibition

of neutrophil activity: Evidence of aberrant cell signaling and incoherent cellular metabolism Scandinavian Journal of Immunology 53: 49–55.

Fortification see Food Fortification: Developed Countries; Developing Countries

FRUCTOSE

N L Keim, US Department of Agriculture, Davis, CA,

USA

P J Havel, University of California at Davis, Davis, CA,

USA

Published by Elsevier Ltd.

Fructose, a monosaccharide, is naturally present in

fruits and is used in many food products as a sweetener

This article reviews the properties and sources of

fruc-tose in the food supply, the estimated intake of frucfruc-tose

in Western diets, the intestinal absorption of fructose,

and the metabolism of fructose and its effect on lipid

and glucose metabolism The health implications of

increased consumption of fructose are discussed, and

inborn errors of fructose metabolism are described

Properties and Sources of Fructose

Fructose has a fruity taste that is rated sweeter than

sucrose Sweetness ratings of fructose are between

130% and 180% (in part dependent on the serving

temperature) compared to the standard, sucrose, rated

at 100% Both sucrose and fructose are used extensively

in foods to provide sweetness, texture, and palatability These sugars also contribute to the appearance, preser-vation, and energy content of the food product Natural sources of dietary fructose are fruits, fruit juices, and some vegetables In these foods, fructose is found as the monosaccharide and also as a component

of the disaccharide, sucrose (Table 1) However, the primary source of fructose in Western diets is in sugars added to baked goods, candies, soft drinks, and other beverages sweetened with sucrose and high-fructose corn syrup (HFCS) HFCS is produced by hydrolyzing the starch in corn to glucose using -amylase and glucoamylase This is followed by treatment with glucose isomerase to yield a mixture of glucose and fructose The process typically produces a HFCS com-posed of 42% fructose, 50% glucose, and 8% other sugars (HFCS-42) By fractionation, a concentrated fructose syrup containing 90% fructose can be isolated (HFCS-90) HFCS-42 and HFCS-90 are blended to produce HFCS-55, which is 55% fructose, 41% glucose, and 4% other sugars HFCS-55 is the pre-ferred sweetener used by the soft drink industry, although HFCS-42 is also commonly used as a sweet-ener in many processed food products Concentrated

Ngày đăng: 03/12/2015, 14:01

TỪ KHÓA LIÊN QUAN

🧩 Sản phẩm bạn có thể quan tâm